(Stroke. 2005;36:2060.)
© 2005 American Heart Association, Inc.
Editorials |
From the Doris & Stanley Tananbaum Stroke Center, Neurological Institute, Columbia University Medical Center, New York, NY
Correspondence to J.P. Mohr, MS, MD, Doris & Stanley Tananbaum Stroke Center, Neurological Institute, Columbia University Medical Center, 710 West 168th Street, New York, NY 10032. E-mail jpm10@columbia.edu
Key Words: cerebral arteriovenous malformations child cerebral hemorrhage
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
Although intracranial hemorrhages,1 interest in brain arteriovenous malformations (BAVMs) is expanding from its origins as a neuropathologic curiosity to the treatment-oriented specialties of neurological surgery, interventional neuroradiology, radiosurgery/therapy, and clinical neurology, and is even emerging as a subject in neuroepidemiology.
Recent insights from uncontrolled series: argue for some genetic derangements in the origin of some of the lesions2,3; have revised some issues of pathophysiology47; track the risk of hemorrhage over time8; suggest the risk for hemorrhage can be predicted by vascular factors discoverable by noninvasive or minimally invasive imaging9,10; indicate many initial hemorrhage syndromes are mild,11 more so than that caused by non-BAVM parenchymal or aneurysmal subarachnoid hemorrhages12; have reassessed the outcomes from intervention in a variety of forms after initial hemorrhage1315; raise questions concerning the safety and value of intervention before hemorrhage16,17; and support a proposal for randomized trials for BAVMs discovered before rupture,18,19 to name but a few of the directions in which work is proceeding in this field.
The prevalence of BAVMs is difficult to estimate, given the lack of a population subject to uniform brain imaging.20 Some insights are provided from rare studies from the likes of uniform magnetic resonance screening of clinically normal recruitees for the German Air Force,21 showing a relative frequency of <0.7% of asymptomatic brain lesions, including among them BAVMs. However, most information comes from nonuniform imaging done in recently reported large prospective population settings, in which 0.5 of 100 000 cases of BAVM discovered
Related Article:
Stroke 2005 36: 2099-2104.
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |